KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Amortization of Deferred Charges (2016 - 2026)

National Health Investors filings provide 17 years of Amortization of Deferred Charges readings, the most recent being $854000.0 for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges fell 12.68% to $854000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $3.3 million, a 29.23% decrease, with the full-year FY2025 number at $3.4 million, down 9.41% from a year prior.
  • Amortization of Deferred Charges hit $854000.0 in Q1 2026 for National Health Investors, up from -$1.4 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $4.5 million in Q3 2025 to a low of -$3.0 million in Q4 2023.
  • Median Amortization of Deferred Charges over the past 5 years was $148000.0 (2023), compared with a mean of $549882.4.
  • The widest YoY moves for Amortization of Deferred Charges: up 1979.37% in 2023, down 4357.14% in 2023.
  • National Health Investors' Amortization of Deferred Charges stood at $70000.0 in 2022, then tumbled by 4357.14% to -$3.0 million in 2023, then surged by 75.2% to -$739000.0 in 2024, then plummeted by 92.96% to -$1.4 million in 2025, then skyrocketed by 159.89% to $854000.0 in 2026.
  • The last three reported values for Amortization of Deferred Charges were $854000.0 (Q1 2026), -$1.4 million (Q4 2025), and $4.5 million (Q3 2025) per Business Quant data.